Eam Global Investors LLC Kodiak Sciences Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$45.05 - $59.27 $897,396 - $1.18 Million	-19,920 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$42.74 - $66.25 $1.27 Million - $1.97 Million	-29,736 Reduced 59.88%	19,920 $1.08 Million
Q1 2020 May 13, 2020	BUY	$38.18 - $73.95 $238,892 - $462,705	6,257 Added 14.42%	49,656 $2.37 Million
Q4 2019 Feb 10, 2020	SELL	$13.9 - $76.65 $757,188 - $4.18 Million	-54,474 Reduced 55.66%	43,399 $3.12 Million
Q3 2019 Nov 13, 2019	BUY	$10.24 - $17.57 $1 Million - $1.72 Million	97,873 New	97,873 $1.41 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $450M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.